Alira Health Acquires BEPATIENT, A Step Forward in Humanizing Healthcare
28.10.2021 10:00:00 EEST | Business Wire | Press release
Alira Health (www.alirahealth.com), a leading technology-enabled services provider, announced that it has acquired BEPATIENT, a European healthcare technology company. BEPATIENT offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical technology companies, associations, and public institutions and is one of the earliest VC-backed players in this space. The company provides clinical solutions for virtual trials and Real-World Evidence (RWE) as well as digital therapeutics for prevention and care management. This acquisition brings unparalleled technology and data capabilities to Alira Health’s full spectrum of patient-centric services that help providers, payers and suppliers uncover opportunity, accelerate innovation, and improve outcomes for patients.
“Every healthcare company says that they are patient-centric. Our acquisition of BEPATIENT demonstrates our dedication to patient-centricity and our investment in Real-World Evidence to power healthcare transformation,” said Benjamin Chambon, Co-founder and Chief Commercial Officer of Alira Health. “The future of healthcare is rooted in taking a patient-centric approach to every aspect of the industry. BEPATIENT is a linchpin in our strategy to transform and humanize healthcare. “
“BEPATIENT is a pioneer in the new clinical research and RWE world that puts patients at the heart of the healthcare ecosystem. We are excited to join Alira Health, a company that is equally passionate about the importance of patient empowerment and engagement in healthcare transformation.” said Frédéric Durand-Salmon, BEPATIENT’s CEO and Founder.
Frédéric Durand-Salmon will join Alira Health as VP of Clinical Digital Solutions. He will be one of Alira Health’s leaders in global software development and services initiatives that focus on synergies among the company’s Patient Engagement, Clinical, Global Market Access, RWE, and Management Consulting practices and BEPATIENT’s health platform.
About BEPATIENT:
BEPATIENT is a French company that has a comprehensive and modular core platform, enabling patients to be connected at home to Healthcare Professionals and to generate value-added Real-World Evidence (RWE) data. The BEPATIENT portfolio of solutions is structured around two activities: clinical research digitalization via direct-to-patient virtual trials technologies and digital therapeutics. BEPATIENT’s activities are mainly concentrated in EMEA and cover a wide range of therapeutic areas.
About Alira Health:
Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. We provide a suite of integrated services designed to help healthcare and life science companies innovate and grow across their solutions lifecycle.
Alira Health was founded in 1999 and is based in Framingham, MA, U.S. Alira Health has offices in San Francisco, CA, U.S.; Paris, France; Barcelona, Spain; Munich, Germany; Milan, Bologna and Verona, Italy; and Basel and Geneva, Switzerland; and Cambridge, UK.
Learn more at https://www.alirahealth.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005109/en/
Contact information
Media Contact:
Susan Irving
Vice President of Global Marketing
Susan.irving@alirahealth.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage and C3 AI Partner on Network-Enabled, Agentic AI Field Services Solution for Mobile Workforces11.2.2026 10:30:00 EET | Press release
Vonage, part of Ericsson (NASDAQ: ERIC), today announced a strategic collaboration with C3 AI (NYSE: AI), a leading Enterprise AI application software provider, to launch C3 AI Field Services, a module of the C3 AI Asset Performance Suite of products, integrated with Vonage APIs. The AI-first module combines C3 AI’s powerful Enterprise AI capabilities with Vonage’s cutting-edge Communications APIs (Voice and Video) and Network APIs (Quality on Demand and Verify), to deliver superior performance, reliability and experiences for mobile enterprise field operations. This collaboration builds on a broader network-powered solutions offering from Vonage where application-aware networking, including advanced connectivity capabilities such as Quality on Demand (QoD), can be applied to support critical field workflows. Quality on Demand is the first advanced network API being showcased¹ and represents one component of Vonage’s larger vision for network intelligence that aligns network behavior w
Mobileum and NOHOLD Launch White-Labeled AI Assistant Offering for Telecom Enterprise Customers11.2.2026 10:00:00 EET | Press release
Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, and NOHOLD, a leader in enterprise-grade AI assistant platforms, have announced the launch of a new white-labeled AI Assistant solution designed specifically for telecom operators serving small and medium-sized enterprises (SME/SMBs). The new offering builds on the strategic AI alliance announced in September 2025, moving from concept to a market-ready solution. Telecom operators can now offer branded AI Assistant services that help SME/SMBs enhance customer engagement, drive sales, and improve productivity through AI technology, with operators providing the tools so SME/SMBs avoid managing complex AI themselves. As traditional connectivity revenues continue to be under pressure, SME/SMBs are seeking value-added digital services from their telecom providers. With AI Assistants, operators can deliver easy-to-use, subscription-based solutions that help SME/SMBs automate support and sales, strengthen
Galderma Expands Restylane ® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™11.2.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in Japan.1,2 The products – designed for injection into the mid-to-deep dermis for the correction of moderate to severe facial wrinkles and folds – are now commercially available in the market.1,2 Restylane Defyne and Refyne leverage the unique balance of softness, flexibility, and support delivered by Galderma’s proprietary OBT – designed to move in harmony with facial expressions while maintaining shape and lift – and are the first and only hyaluronic acid injectables clinically proven to restore youthful facial expressions.1,2,5-11 Restylane Refyne offers a smooth, flexible gel, ideal for delicate, highly expressive areas, while Restylane Defyne provides support for areas such as the jawline and deeper facial folds.1,2,5-11 These launches mark a major milestone for Galderma and represent an
Suzano Reports Record Sales and Continued Improvements in Operational Efficiency in 202511.2.2026 01:44:00 EET | Press release
Suzano, the world’s largest pulp producer, announces its results for both the final quarter (4Q25) and the full year (2025), reporting record annual sales volumes and net revenue. The company also reported an improvement in its cash cost of pulp production, reflecting the drive for improved operational efficiency. Pulp and paper sales reached 14.2 million tonnes, a 15% increase compared to 2024. This performance was driven primarily by the strong operational contribution of the Ribas do Rio Pardo pulp mill, which began production in July 2024, and the company’s paper mills in the United States. As a result, Suzano’s full‑year net revenue reached a record R$50 billion in 2025. The company’s consistent focus on efficiency and cost discipline also contributed to a meaningful reduction in the cash cost of pulp production. Excluding downtime, the annual cash cost was R$817 per tonne, reaching its lowest annual level since 2021. Operational efficiency also helped Suzano deliver operating cas
Eclipse Signs Partnership Agreement With BNP Paribas to Power the Next Stage of Growth11.2.2026 01:05:00 EET | Press release
Eclipse, a leading battery storage, development, and energy trading company, and BNP Paribas, one of the largest banks in the Eurozone, today announced a strategic partnership to accelerate the deployment of Battery Energy Storage Systems (BESS) and strengthen Europe's energy resilience. This partnership includes a strategic equity investment in Eclipse by BNP Paribas. Through its proprietary algo trading software, Flowstream, Eclipse optimizes battery energy storage assets in real-time for its own and third-party assets. As an integrated BESS player, Eclipse develops, owns, and operates industrial-scale energy assets. The company currently has a pipeline of 16 projects in France and Belgium, representing a total capacity of 850 MW. The partnership with BNP Paribas provides asset owners with tailored financing solutions for BESS projects, as well as hedging instruments to manage merchant risk and reduce asset-level cost of capital. This collaboration will enable Eclipse and BNP Paribas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom